by admin | May 26, 2026 | News & Opinions
By RegMedNet – A new clinical trial is evaluating whether a single mesenchymal stem cell infusion can stabilize cognitive decline in patients with mild cognitive impairment or early Alzheimer’s disease. A new investigator-initiated clinical trial at the...
by admin | May 21, 2026 | News & Opinions
By UT MD Anderson – The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today announced that the Food and Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug...
by admin | May 16, 2026 | News & Opinions
Volume 16 Over 15,000 Subscribers From the Editor Eve Herold Editor-in-Chief In the scheme of things, longevity science is a relatively new field. But we’re starting to reap the rewards of several decades spent identifying the foundational causes of the biological...
by admin | May 13, 2026 | News & Opinions
By Camryn Haines – Texas A&M University – Researchers have successfully regenerated skeletal and connective tissue — even if not perfectly formed — demonstrating the next, critical step in limb regeneration. For centuries, the inability to regrow lost...
by admin | May 12, 2026 | News & Opinions
by Inka Burow, Hannover Medical School – PHYS.Org – Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such as macrophages, in medium-sized bioreactors. These immune cells can be derived...
